PF-08653945 and PF-08653944 for Overweight or Obesity

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

Recruiting Phase 2 Interventional Study
Overweight Obesity Overweight and/or Obesity Overweight or Obesity Overnutrition Nutrition Disorders Nutritional and Metabolic Diseases Body Weight
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
872 (estimated)
Sponsor
Pfizer · Industry
Who this trial is looking for

This trial is looking for adults aged 18 or older who are overweight or obese. Participants will take the study drugs alone or together to see if they help with weight loss compared to a placebo.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years or older
  • I have obesity with a BMI of 30 to 50
  • I have overweight with a BMI of 27 to less than 30 and a weight-related condition

You may not be able to join if

  • I have diabetes
  • I have lost more than 5% of my body weight in the past 12 weeks
  • I have used weight loss medications in the past 12 weeks
  • I have had or plan to have surgery for obesity
  • I am pregnant or breastfeeding
  • I am unable or unwilling to follow contraceptive requirements

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Eligible participants for this study include: * adults aged 18 years or older with * obesity (BMI of 30.0 kg/m2 to 50.0 kg/m2) or with * overweight (BMI of 27.0 kg/m2 to \<30.0 kg/m2) who also have at least 1 prespecified weight-related comorbidity (hypertension, dyslipidemia, …
Contacts

Pfizer CT.gov Call Center

1-800-718-1021

ClinicalTrials.gov_Inquiries@pfizer.com

CONTACT